520 related articles for article (PubMed ID: 23686230)
41. APOBEC3A damages the cellular genome during DNA replication.
Green AM; Landry S; Budagyan K; Avgousti DC; Shalhout S; Bhagwat AS; Weitzman MD
Cell Cycle; 2016; 15(7):998-1008. PubMed ID: 26918916
[TBL] [Abstract][Full Text] [Related]
42. Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartments.
Fourati S; Lambert-Niclot S; Soulie C; Wirden M; Malet I; Valantin MA; Tubiana R; Simon A; Katlama C; Carcelain G; Calvez V; Marcelin AG
AIDS; 2014 Feb; 28(4):487-91. PubMed ID: 24401644
[TBL] [Abstract][Full Text] [Related]
43. Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure.
McDaniel YZ; Wang D; Love RP; Adolph MB; Mohammadzadeh N; Chelico L; Mansky LM
Nucleic Acids Res; 2020 Feb; 48(3):1353-1371. PubMed ID: 31943071
[TBL] [Abstract][Full Text] [Related]
44. CBFß and HIV Infection.
Kim DY; Gross JD
Adv Exp Med Biol; 2017; 962():415-431. PubMed ID: 28299671
[TBL] [Abstract][Full Text] [Related]
45. Natural APOBEC3C variants can elicit differential HIV-1 restriction activity.
Anderson BD; Ikeda T; Moghadasi SA; Martin AS; Brown WL; Harris RS
Retrovirology; 2018 Dec; 15(1):78. PubMed ID: 30558640
[TBL] [Abstract][Full Text] [Related]
46. Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
Cao W; Wu W
Methods Mol Biol; 2018; 1699():75-81. PubMed ID: 29086369
[TBL] [Abstract][Full Text] [Related]
47. Cytidine deamination induced HIV-1 drug resistance.
Mulder LC; Harari A; Simon V
Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5501-6. PubMed ID: 18391217
[TBL] [Abstract][Full Text] [Related]
48. Small-molecule inhibition of HIV-1 Vif.
Nathans R; Cao H; Sharova N; Ali A; Sharkey M; Stranska R; Stevenson M; Rana TM
Nat Biotechnol; 2008 Oct; 26(10):1187-92. PubMed ID: 18806783
[TBL] [Abstract][Full Text] [Related]
49. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression.
Peng G; Greenwell-Wild T; Nares S; Jin W; Lei KJ; Rangel ZG; Munson PJ; Wahl SM
Blood; 2007 Jul; 110(1):393-400. PubMed ID: 17371941
[TBL] [Abstract][Full Text] [Related]
50. A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.
Nakano Y; Aso H; Soper A; Yamada E; Moriwaki M; Juarez-Fernandez G; Koyanagi Y; Sato K
Retrovirology; 2017 May; 14(1):31. PubMed ID: 28482907
[TBL] [Abstract][Full Text] [Related]
51. E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure.
Fourati S; Malet I; Lambert S; Soulie C; Wirden M; Flandre P; Fofana DB; Sayon S; Simon A; Katlama C; Calvez V; Marcelin AG
AIDS; 2012 Aug; 26(13):1619-24. PubMed ID: 22695298
[TBL] [Abstract][Full Text] [Related]
52. The restriction factors of human immunodeficiency virus.
Harris RS; Hultquist JF; Evans DT
J Biol Chem; 2012 Nov; 287(49):40875-83. PubMed ID: 23043100
[TBL] [Abstract][Full Text] [Related]
53. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.
Chiu YL; Greene WC
Annu Rev Immunol; 2008; 26():317-53. PubMed ID: 18304004
[TBL] [Abstract][Full Text] [Related]
54. DRONE: Direct Tracking of DNA Cytidine Deamination and Other DNA Modifying Activities.
Sasaki T; Kudalkar SN; Bertoletti N; Anderson KS
Anal Chem; 2018 Oct; 90(20):11735-11740. PubMed ID: 30256094
[TBL] [Abstract][Full Text] [Related]
55. Deaminase-Dead Mouse APOBEC3 Is an
Stavrou S; Zhao W; Blouch K; Ross SR
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
[TBL] [Abstract][Full Text] [Related]
56. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
[TBL] [Abstract][Full Text] [Related]
57. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
[TBL] [Abstract][Full Text] [Related]
58. [Antiviral defense by APOBEC3 family proteins].
Takaori A
Uirusu; 2005 Dec; 55(2):267-72. PubMed ID: 16557012
[TBL] [Abstract][Full Text] [Related]
59. Characterization of molecular attributes that influence LINE-1 restriction by all seven human APOBEC3 proteins.
Renner TM; Bélanger K; Goodwin LR; Campbell M; Langlois MA
Virology; 2018 Jul; 520():127-136. PubMed ID: 29860216
[TBL] [Abstract][Full Text] [Related]
60. Apolipoprotein B mRNA-editing, catalytic polypeptide cytidine deaminases and retroviral restriction.
Koito A; Ikeda T
Wiley Interdiscip Rev RNA; 2012; 3(4):529-41. PubMed ID: 22549984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
